Mice with inactivation of the Tuberous sclerosis complex-1 (Tsc1) gene in glia (Tsc1 GFAP CKO mice) have deficient astrocyte glutamate transporters and develop seizures, suggesting that abnormal glutamate homeostasis contributes to neurological abnormalities in these mice. We examined the hypothesis that Tsc1 GFAP CKO mice have elevated extracellular brain glutamate levels that may cause neuronal death, abnormal glutamatergic synaptic function, and associated impairments in behavioral learning. In vivo microdialysis documented elevated glutamate levels in hippocampi of Tsc1 GFAP CKO mice and several cell death assays demonstrated neuronal death in hippocampus and neocortex. Impairment of long-term potentiation (LTP) with tetanic stimulation was observed in hippocampal slices from Tsc1 GFAP CKO mice and was reversed by low concentrations of NMDA antagonist, indicating that excessive synaptic glutamate directly inhibited LTP. Finally, Tsc1 GFAP CKO mice exhibited deficits in two hippocampaldependent learning paradigms. These results suggest that abnormal glutamate homeostasis predisposes to excitotoxic cell death, impaired synaptic plasticity and learning deficits in Tsc1 GFAP CKO mice.
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Introduction
Tuberous sclerosis complex (TSC) is a relatively common multi-system genetic disease caused by mutation of either the TSC1 or TSC2 gene (Crino et al., 2006; Kwiatkowski, 2003; Sparagana and Roach, 2000) . Neurological symptoms are usually the most disabling clinical problems associated with TSC and typically include seizures, autism, mental retardation, and learning disabilities. Current treatments of the neurological manifestations of TSC are purely symptom-based and are largely ineffective. Thus, understanding the pathophysiology of TSC is critical for developing novel, more effective therapies for the neurological symptoms in TSC. The neuropathological hallmark of brains from TSC patients are areas of disrupted cortical lamination, termed tubers, which likely represent the epileptogenic foci for seizures and also contribute to the cognitive deficits in TSC (Doherty et al., 2005; Goodman et al., 1997) . Cortical tubers demonstrate dramatic histopathological abnormalities in glia, suggesting that defective glial function may be centrally involved in the pathogenesis of TSC (Gutmann et al., 2000; Ess et al., 2004) . In this regard, we have previously demonstrated that conditional Tsc1 gene inactivation primarily in glia of mice (Tsc1 GFAP CKO mice) results in progressive epilepsy, encephalopathy, and premature death (Uhlmann et al., 2002) . However, the specific mechanisms causing neuronal dysfunction in Tsc1 GFAP CKO mice are unknown. Glutamate, the major excitatory neurotransmitter in mammalian brain, may have detrimental effects on neurons when present in excessive amounts and has been implicated in the pathogenesis of a number of neurological disorders. Impairment of glutamate uptake by astrocytes can lead to excessive extracellular glutamate levels, resulting in abnormal synaptic function under some conditions (Mennerick and Zorumski, 1994; Tong and Jahr, 1994) , impaired long-term potentiation (Katagiri et al., 2001) , and excitotoxic neuronal death (Rothstein et al., 1996; Tanaka et al., 1997) , which may all cause cognitive dysfunction. Furthermore, inactivation of
